CurrentArizona Complete HealthPolicy CP.MP.133

Posterior Tibial Nerve Stimulation for Voiding Dysfunction

Defines medical necessity, coverage criteria, and coding guidance for percutaneous posterior tibial nerve stimulation to treat overactive bladder (OAB) and related voiding dysfunction for Arizona Complete Health members.

Policy Summary

PayerArizona Complete Health

PolicyPosterior Tibial Nerve Stimulation for Voiding Dysfunction

Policy CodePolicy CP.MP.133

Change TypeLanguage clarification and coding updates

Effective Date

Next Review Date

Key ActionObtain prior authorization and document failure of conservative management and a 30-minute weekly PTNS regimen for 12 weeks when billing CPT 64566.

SourceLink

POLICY UPDATE CHANGES

Replaced 'investigational' language with 'insufficient evidence to support' for certain uses of PTNS and implantable tibial nerve stimulation.

Clarified conservative management examples to include behavioral therapies such as bladder training and pelvic floor muscle training and broadened medication language to 'medications used with the intent to treat OAB.'

Updated coding and descriptions and removed ICD-10 CM Diagnosis Code table.

12initial weekly 30-minute PTNS sessions required for trial

monthlymaintenance treatment frequency after initial response

30 mintypical duration per PTNS treatment session

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage and Medical Necessity Criteria

Initial PTNS Therapy

Covered when ALL of the following are met:

Initial PTNS criteria: A. Diagnosis of overactive bladder (OAB); B. There has been a failure of conservative medical management (e.g., behavioral therapies such as bladder training or pelvic floor muscle training, or pharmacotherapy with oral medications used with the intent to treat OAB), unless conservative management is not desired or is medically contraindicated; C. Service is provided in accordance with the standard treatment regimen of 30-minute weekly sessions for 12 weeks.

Responders often show some improvement after 6-8 sessions.

Maintenance PTNS Therapy

Covered when ALL of the following are met:

Maintenance therapy: Once-a-month maintenance treatments with PTNS are medically necessary for patients who experience significant improvement in their OAB symptoms after the 12 initial treatments; treatment frequency may vary depending on return of symptoms.

Limitations on Duration and Use

Duration/insufficient evidence: There is insufficient evidence to support use of PTNS beyond 12 months or when there is no improvement in urinary dysfunction.

Implantable tibial nerve stimulation devices currently have limited evidence to support their use for voiding dysfunction.

Claims submitted with CPT codes for implantation, revision/removal, or programming of implantable posterior tibial nerve stimulation systems are not supported by evidence and are not covered under this policy. Examples of CPT codes that do not support medical necessity include 0587T, 0588T, 0589T, and 0590T. Providers billing these codes risk denial.

There is insufficient evidence to support the use of posterior tibial nerve stimulation beyond 12 months or the use of implantable tibial nerve stimulation devices for urinary voiding dysfunction. Implantable tibial nerve neuromodulation systems are currently under investigation and available published evidence is limited; therefore use of PTNS beyond one year or implantation of tibial nerve systems is considered not supported by the evidence in this policy.

Coding Guidance

CPT codes that support medical necessityCPTCovered

64566

Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming

CPT codes that do not support medical necessityCPTNot Covered

0587T	Percutaneous implantation or replacement of integrated single device neurostimulation system for bladder dysfunction including electrode array and receiver or pulse generator, including analysis, programming and imaging guidance when performed, posterior tibial nerve.
0588T	Revision or removal of percutaneously placed integrated single device neurostimulation system for bladder dysfunction including electrode array and receiver or pulse generator, including analysis, programming, and imaging guidance when performed, posterior tibial nerve.
0589T	Electronic analysis with simple programming of implanted integrated neurostimulation system for bladder dysfunction (eg, electrode array and receiver), including contact group(s), amplitude, pulse width, frequency (Hz), on/off cycling, burst, dose lockout, patient-selectable parameters, responsive neurostimulation, detection algorithms, closed-loop parameters, and passive parameters, when performed by physician or other qualified health care professional, posterior tibial nerve, 1-3 parameters.
0590T	Electronic analysis with complex programming of implanted integrated neurostimulation system for bladder dysfunction (eg, electrode array and receiver), including contact group(s), amplitude, pulse width, frequency (Hz), on/off cycling, burst, dose lockout, patient-selectable parameters, responsive neurostimulation, detection algorithms, closed-loop parameters, and passive parameters, when performed by physician or other qualified health care professional, posterior tibial nerve, 4 or more parameters.

Provider Requirements and Billing Actions

Prior Authorization

Prior Authorization and Supported Codes

Prior authorization is required per plan rules for posterior tibial nerve stimulation (PTNS) services. Claims billed with CPT 64566 (posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming) require prior authorization. Implantable tibial nerve stimulation system procedure and device codes (CPT 0587T–0590T) are not supported and should not be authorized.

Prior authorization required for CPT 64566
CPT 0587T–0590T are not supported / not covered

Documentation Required

Conservative Management Required Before PTNS

Before initiating PTNS, providers must document failure of conservative medical management for overactive bladder (OAB) unless such measures are not desired by the patient or are medically contraindicated. Conservative management includes behavioral therapies (e.g., bladder training, pelvic floor muscle training) and pharmacotherapy with oral medications commonly used to treat OAB. Documentation of prior conservative therapies and the patient's response (or contraindication) must be included in the medical record.

Definitions

inv-13: Posterior tibial nerve stimulation (PTNS) 6 definition and brief description

DefinitionA minimally invasive electrical neuromodulation technique that stimulates the posterior tibial nerve via a percutaneous needle electrode near the ankle to indirectly modulate sacral nerve inputs controlling bladder function.

Typical procedure detailsA 34‑gauge needle electrode is inserted ~5 cm cephalad to the medial malleolus and 2 cm posterior to the tibia, with a surface electrode on the medial foot connected to a low‑voltage stimulator.

Stimulation parametersStimulation delivered at about 0.5–9 mA and 20 Hz for 30 minutes per treatment session.

Treatment regimenInitial regimen typically 12 weekly 30‑minute sessions; some responders show improvement after 6–8 sessions; maintenance sessions may be delivered monthly as needed.

Investigational alternativesSeveral implantable tibial nerve neuromodulation systems (including miniature leadless implants) are under investigation but currently have limited evidence to support their use.

Background

Overactive bladder (OAB) is a voiding dysfunction characterized by urinary urgency, frequency, urge incontinence, and nocturia that can impair quality of life. Posterior tibial nerve stimulation (PTNS) is a minimally invasive neuromodulation technique that delivers electrical stimulation to the posterior tibial nerve near the ankle (via a percutaneous needle electrode and a surface electrode on the foot) to indirectly modulate sacral nerves controlling bladder function. Typical stimulation parameters reported in the literature are 0.5–9 mA at 20 Hz for 30 minutes per session. Initial treatment regimens generally consist of 12 weekly 30-minute sessions, with some patients showing improvement after 6–8 sessions; maintenance sessions may be required, commonly delivered about once monthly for responders.

Policy Revision History

2024-07criteria_update

Updated Criteria I.B to replace specific medication classes with broader wording 'medications used with the intent to treat OAB' and clarified behavioral therapy examples; references reviewed and updated.

2024-08-21terminology_and_evidence_stance_update

Replaced 'investigational' language with 'insufficient evidence to support' for certain uses of PTNS and implantable tibial nerve stimulation; revised header labels and updated references; specialist review and approval completed.

2024-08-22criteria_clarification